The Journal of Urology
Volume 180, Issue 1 , Pages 38-46 , July 2008

Issues Faced by Unaffected Men With a Family History of Prostate Cancer: A Multidisciplinary Overview

  • C.E. Wakefield

      Affiliations

    • Psychosocial Research Group, Department of Medical Oncology, Prince of Wales Hospital, Randwick, Australia
    • School of Psychiatry, Faculty of Medicine, University of New South Wales, Australia
    • Corresponding Author InformationCorrespondence: Psychosocial Research Group (PRG), Dickinson 3, Department of Medical Oncology, Prince of Wales Hospital, Randwick, NSW 2031, Sydney, Australia (telephone: 0061-2-9382-4229; FAX: 0061-2-9382-3372).
    • ,
  • B. Meiser

      Affiliations

    • Psychosocial Research Group, Department of Medical Oncology, Prince of Wales Hospital, Randwick, Australia
    • School of Psychiatry, Faculty of Medicine, University of New South Wales, Australia
    • ,
  • C.L. Gaff

      Affiliations

    • Genetic Health Services, Victoria and Department of Medicine, The University of Melbourne, Victoria, Australia
    • ,
  • A. Barratt

      Affiliations

    • School of Public Health, University of Sydney, Sydney, Australia
    • ,
  • M.I. Patel

      Affiliations

    • Department of Surgery, University of Sydney, Sydney, Australia
    • ,
  • G. Suthers

      Affiliations

    • Familial Cancer Unit, Department of Genetic Medicine, Women's & Children's Hospital, North Adelaide and Department of Paediatrics, University of Adelaide, Adelaide, South Australia
    • ,
  • E.A. Lobb

      Affiliations

    • Medical Psychology Research Unit, University of Sydney, Camperdown, Australia
    • Western Australia Center for Cancer & Palliative Care, Curtin University of Technology, Perth, Western Australia
    • ,
  • J. Ramsay

      Affiliations

    • Urology Oncology Program, Collaboration for Cancer Outcomes Research & Evaluation, Liverpool Hospital, Liverpool
    • ,
  • G.J. Mann

      Affiliations

    • Westmead Institute for Cancer Research, University of Sydney at Westmead, Millennium Institute, Westmead, Australia

Received 6 August 2007

References 

  1. Roehl KA, Loeb S, Antenor JA, Corbin N, Catalona WJ. Characteristics of patients with familial versus sporadic prostate cancer. J Urol. 2006;176:2438
  2. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, et al. Hereditary prostate cancer: epidemiologic and clinical features. J Urol. 1993;150:797
  3. Edwards SM, Eeles RA. Unravelling the genetics of prostate cancer. Am J Med Genet C Semin Med Genet. 2004;129:65
  4. Zeegers MP, Jellema A, Ostrer H. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer. 2003;97:1894
  5. Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P. Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer. 2003;107:797
  6. Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int. 2003;91:789
  7. Sinclair CS, Berry R, Schaid D, Thibodeau SN, Couch FJ. BRCA1 and BRCA2 have a limited role in familial prostate cancer. Cancer Res. 2000;60:1371
  8. Ilic D, O'Connor D, Green S, Wilt T. Screening for prostate cancer: a Cochrane systematic review. Cancer Causes Control. 2007;18:279
  9. Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:917
  10. Ciatto S, Gervasi G, Bonardi R, Frullini P, Zendron P, Lombardi C, et al. Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991–1994). Eur J Cancer. 2005;41:411
  11. Oberaigner W, Horninger W, Klocker H, Schonitzer D, Stuhlinger W, Bartsch G. Reduction of prostate cancer mortality in Tyrol, Austria, after introduction of prostate specific antigen testing. Am J Epidemiol. 2006;164:376
  12. Coldman AJ, Phillips N, Pickles TA. Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity. CMAJ. 2003;168:31
  13. Roemeling S, Roobol MJ, de Vries SH, Gosselaar C, van derKwast TH, Schroder FH. Prevalence, treatment modalities and prognosis of familial prostate cancer in a screened population. J Urol. 2006;175:1332
  14. Postma R, Schroder FH, van Leenders GJ, Hoedemaeker RF, Vis AN, Roobol MJ, et al. Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)–Section Rotterdam (A comparison of two rounds of screening). Eur Urol. 2007;52:89
  15. Spencer BA, Babey SH, Etzioni DA, Ponce NA, Brown ER, Yu H, et al. A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma. Cancer. 2006;106:765
  16. Bratt O, Kristoffersson U, Lundgren R, Olsson H. Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing. Urology. 1997;50:360
  17. Cormier L, Guillemin F, Valeri A, Fournier G, Cussenot O, Mangin P, et al. Impact of prostate cancer screening on health-related quality of life in at-risk families. Urology. 2002;59:901
  18. Bratt O, Damber JE, Emanuelsson M, Kristoffersson U, Lundgren R, Olsson H, et al. Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer. 2000;36:235
  19. Sweetman J, Watson M, Norman A, Bunstead Z, Hopwood P, Melia J, et al. Feasibility of familial PSA screening: psychosocial issues and screening adherence. Br J Cancer. 2006;94:507
  20. Beebe-Dimmer JL, Wood DP, Gruber SB, Chilson DM, Zuhlke KA, Claeys GB, et al. Risk perception and concern among brothers of men with prostate carcinoma. Cancer. 2004;100:1537
  21. Vadaparampil ST, Jacobsen PB, Kash K, Watson IS, Saloup R, Pow-Sang J. Factors predicting prostate specific antigen testing among first-degree relatives of prostate cancer patients. Cancer Epidemiol Biomarkers Prev. 2004;13:753
  22. Jacobsen PB, Lamonde LA, Honour M, Kash K, Hudson PB, Pow-Sang J. Relation of family history of prostate cancer to perceived vulnerability and screening behavior. Psychooncology. 2004;13:80
  23. Miller SM, Diefenbach MA, Kruus LK, Watkins-Bruner D, Hanks GE, Engstrom PF. Psychological and screening profiles of first-degree relatives of prostate cancer patients. J Bahev Med. 2001;24:247
  24. Gaff CL, Cowan R, Meiser B, Lindeman G. Genetic services for men: the preferences of men with a family history of prostate cancer. Genet Med. 2006;8:771
  25. Bock CH, Peyser PA, Gruber SB, Bonnell SE, Tedesco KL, Cooney KA. Prostate cancer early detection practices among men with a family history of disease. Urology. 2003;62:470
  26. Shah M, Zhu K, Palmer RC, Wu H. Family history of cancer and utilization of prostate, colorectal and skin cancer screening tests in U.S. men. Prev Med. 2007;44:459
  27. Bloom JR, Stewart SL, Oakley-Girvans I, Banks PJ, Chang S. Family history, perceived risk, and prostate cancer screening among African American men. Cancer Epidemiol Biomarkers Prev. 2006;15:2167
  28. Ross LE, Uhler RJ, Williams KN. Awareness and use of the prostate-specific antigen test among African-American Men. J Natl Med Assoc. 2005;97:963
  29. Meiser B, Cowan R, Costello A, Giles GG, Lindeman GJ, Gaff CL. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake. Urology. 2007;70:738
  30. Weinrich SP. Prostate cancer screening in high-risk men: African American Hereditary Prostate Cancer Study Network. Cancer. 2006;106:796
  31. Bratt O, Emanuelsson M, Gronberg H. Psychological aspects of screening in families with hereditary prostate cancer. Scand J Urol Nephrol. 2003;37:5
  32. Weinrich S, Royal C, Pettaway CA, Dunston G, Faison-Smith L, Priest JH, et al. Interest in genetic prostate cancer susceptibility testing among African American men. Cancer Nurs. 2002;25:28
  33. Miesfeldt S, Jones SM, Cohn W, Lippert M, Haden K, Turner BL, et al. Men's attitudes regarding genetic testing for hereditary prostate cancer risk. Urology. 2000;55:46
  34. Diefenbach MA, Schnoll RA, Miller SM, Brower L. Genetic testing for prostate cancer (Willingness and predictors of interest). Cancer Pract. 2000;8:82
  35. Ropka M, Wenzel J, Phillips E, Siadaty M, Philbrick JT. Uptake rates for breast cancer genetic testing: a systematic review. Cancer Epidemiol Biomarkers Prev. 2006;15:840
  36. Burack RC, Wood DP. Screening for prostate cancer (The challenge of promoting informed decision making in the absence of definitive evidence of effectiveness). Med Clin North Am. 1999;83:
  37. Edwards A, Sivell S, Dundon J, Elwyn G, Evans R, Gaff C, et al. Effective Risk Communication in Clinical Genetics: A Systematic Review. In: Cardiff, United Kingdom: Cardiff University; 2006;p. 249
  38. Evans R, Edwards A, Brett J, Bradburn M, Watson E, Austoker J, et al. Reduction in uptake of PSA tests following decision aids: systematic review of current aids and their evaluations. Patient Educ Couns. 2005;58:13
  39. Prostate-specific antigen (PSA) best practice policy (American Urological Association (AUA)). Oncology. 2000;14:267
  40. American Cancer Society. Detailed Guide: Prostate Cancer (Can Prostate Cancer Be Found Early?). http://www.cancer.org/docroot/CRI/content/CRI_2_4_3X_Can_prostate_cancer_be_found_early_36.aspAccessed April 13, 2007
  41. U.S. Preventative Services Taskforce: Screening for prostate cancer: recommendation and rationale. Ann Intern Med. 2002;137::915
  42. Watson E, Jenkins L, Bukach C, Austoker J. The PSA Test and Prostate Cancer: Information for Primary Care. Sheffield, United Kingdom: NHS Cancer Screening Programmes; 2002;
  43. Urological Society of Australia and New Zealand. Screening for prostate cancer. http://www.urosoc.org.au/consumer_health/index.jsp?a=1126157831Accessed April 13, 2007
  44. The Cancer Council Australia: Prostate Cancer Screening Position Statement. http://www.cosa.org.au/documents/Prostate%20Screening%20PosStmt%20MAY2005.pdfAccessed April 13, 2007
  45. Cancer Society of New Zealand: Position Statement: Screening for Cancer of the Prostate. http://www.cancernz.org.nz/Uploads/CSNZ_PS_Prostate_Cancer_Screening.pdfAccessed April 13, 2007
  46. Cormier L, Reid K, Kwan L, Litwin MS. Screening behavior in brothers and sons of men with prostate cancer. J Urol. 2003;169:1715
  47. Cormier L, Kwan L, Reid K, Litwin MS. Knowledge and beliefs among brothers and sons of men with prostate cancer. Urology. 2002;59:895
  48. Taylor KL, DiPlacido J, Redd WH, Faccenda K, Greer L, Perlmutter A. Demographics, family histories, and psychological characteristics of prostate carcinoma screening participants. Cancer. 1999;85:1305
  49. Cormier L, Valeri A, Azzouzi R, Fournier G, Cussenot O, Berthon P, et al. Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing. Prostate. 2002;51:276

 Supported by a Strategic Research Partnership (STREP) Grant (ID SRP, 06-X5) from The Cancer Council of New South Wales and a Career Development Award from the National Health and Medical Research Council, of Australia (ID 350989) (BM).

PII: S0022-5347(08)00580-6

doi: 10.1016/j.juro.2008.03.020

The Journal of Urology
Volume 180, Issue 1 , Pages 38-46 , July 2008

Article Tools

* Image Usage & Resolution